XIAP and central nervous system cancer: Since EDL-360 induced the apoptosis of glioma cells and this effect was augmented when EDL-360 treatment was combined with a XIAP inhibitor (embelin), we investigated the effect of the combination treatment with an inhibitor of apoptosis (decylubiquinone, dUb).